Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/07/2003WO2003064459A1 Peptides for increasing transfection efficiency
08/07/2003WO2003064457A1 A method for inhibiting 'melanoma inhibitory activity' mia
08/07/2003WO2003064453A2 Trojan inhibitors, method for the production and use thereof
08/07/2003WO2003064450A2 Epizootic catarrhal enteritis prevention, treatment and diagnosis
08/07/2003WO2003064449A2 Bioactive keratin peptides
08/07/2003WO2003064448A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli
08/07/2003WO2003064446A2 Plasma protein-binding peptides from bacterial curli
08/07/2003WO2003064402A1 Treatment of male sexual dysfunction
08/07/2003WO2003063904A2 Tissue adhesion formation control
08/07/2003WO2003063899A2 Vaccine adjuvant based on a cd4 0 ligand
08/07/2003WO2003063893A2 Fgfr agonists
08/07/2003WO2003063798A2 Compositions and methods for treatment of infectious and inflammatory diseases
08/07/2003WO2003063782A2 Kappa-pviia-related conotoxins as organ protectants
08/07/2003WO2003063770A2 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/07/2003WO2003063769A2 Vesicle-associated proteins
08/07/2003WO2003063766A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003WO2003063760A2 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
08/07/2003WO2003063759A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
08/07/2003WO2003063725A2 Methods of preventing and treating flavivirus infection in animals
08/07/2003WO2003063688A2 Protein modification and maintenance molecules
08/07/2003WO2003063679A2 Hepatitis e virus clones and methods of their use
08/07/2003WO2003063608A1 A process for the extraction, purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
08/07/2003WO2003063581A2 Compositions and methods for increasing animal size and growth rate
08/07/2003WO2003052091A8 Growth factor modified protein matrices for tissue engineering
08/07/2003WO2003042366A3 A novel saitohin gene and uses of same
08/07/2003WO2003040340A9 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
08/07/2003WO2003030616A3 21132, a human g-protein coupled receptor family member and uses therefor
08/07/2003WO2003025000A3 Peptides capable of modulating immune response
08/07/2003WO2003020916A8 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof
08/07/2003WO2003020911A9 Human schizophrenia gene
08/07/2003WO2003008640A3 Asthma-associated gene
08/07/2003WO2003006689A3 Diagnosis and treatment of diseases associated with altered expression of hipk1
08/07/2003WO2003006618A3 Nucleic acid-associated proteins
08/07/2003WO2003002741A8 Nucleic acids encoding nuclear receptors
08/07/2003WO2002101020A3 A synthetic dna encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors
08/07/2003WO2002088334A9 Chimeric immunoreceptor useful in treating human cancers
08/07/2003WO2002083069A3 Recombinant proteins of orientia tsutsugamushi
08/07/2003WO2002079403A3 Method for modifying plant biomass
08/07/2003WO2002077179A3 Leinamycin biosynthesis gene cluster and its components and their uses
08/07/2003WO2002073062A3 Synthetic molecular spring device
08/07/2003WO2002072792A8 Heterologous fusion protein constructs comprising a leishmania antigen
08/07/2003WO2002072627A3 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
08/07/2003WO2002068615A3 Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives
08/07/2003WO2002068476A3 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
08/07/2003WO2002066642A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/07/2003WO2002053588A3 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci
08/07/2003WO2002052023A3 Position-independent and tissue specific expression of a transgene in milk of transgenic animals
08/07/2003WO2002050274A3 Seleno-cysteine containing protein zsel1
08/07/2003WO2002048192A3 Amidated glucagon-like peptide-1
08/07/2003WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003WO2002045659A9 Novel therapeutics for heart failure and aging
08/07/2003WO2002033119A3 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
08/07/2003WO2002030973A8 The caveolin-1 gene and polypeptide encoded thereby and methods of use thereof
08/07/2003WO2002024943A3 Method of identifying osteoregenerative agents using differential gene expression
08/07/2003WO2002022822A3 Plant derived bag homologues
08/07/2003WO2002020850A3 Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits
08/07/2003WO2002020848A3 Gene and sequence variation associated with cancer
08/07/2003WO2002020751A3 Hyperglycosylated polypeptides
08/07/2003WO2002012331A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer
08/07/2003WO2002008381A3 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
08/07/2003WO2002004015A9 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
08/07/2003WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
08/07/2003WO2001098524A3 Protein-protein interactions
08/07/2003WO2001090149A3 G protein-coupled receptors
08/07/2003WO2001057252A3 Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes
08/07/2003US20030150026 Genes involved in brassinosteroid hormone action in plants
08/07/2003US20030150019 Comprises plant viral RNA sequences comprising cis-acting replication elements for transfection and expression of heterologous proteins in plants such as tobacco
08/07/2003US20030150018 Comprises nucleotide sequences coding insecticidal proteins (cry proteins) for insect resistance; biological pest control
08/07/2003US20030150017 Preparing pineapple plant resistance to nematode infection and/or infestation; disease resistant plants; nematocides
08/07/2003US20030150014 Maize cellulose synthases and uses thereof
08/07/2003US20030150010 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
08/07/2003US20030150005 Rodent model comprising genes coding hypoxia inducible factor (HIF) for detection of hypoxic tissue
08/07/2003US20030150004 Transgenic mice expressing human CAR receptor (retinoic acid receptors), wherein activity is increased via administration of 1,4-bis(2-(3,5-dichloropyridyloxy))benzene; cytochromes
08/07/2003US20030150003 Novel apolipoprotein gene involved in lipid metabolism
08/07/2003US20030150002 Generating transgenic, disease resistant cattle using cryopresevred regenerated mammalian oocytes
08/07/2003US20030149999 Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149995 Compound screening methods
08/07/2003US20030149531 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/07/2003US20030149256 Transferrin polynucleotides, polypeptides, and antibodies
08/07/2003US20030149255 Bird diagnostics and treatments
08/07/2003US20030149254 Retroviral vector comprising green fluorescent reporter protein for use as diagnostic tool in genetic engineering
08/07/2003US20030149249 Process for isolation of osteopontin from milk
08/07/2003US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
08/07/2003US20030149243 Enhanced oil seed protein recovery
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149241 Nucleotide sequences coding osteogenic protein for induction/differentiation and/or treatment of bone, cartilage and other connective tissue defects; wound healing agents
08/07/2003US20030149240 Yeast cell model for monitoring and detecting modulators of serine-threonine kinase (CDC7) activity; antiproliferative agents; enzyme inhibitors
08/07/2003US20030149239 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030149238 Novel compounds
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030149236 Nucleotide sequences coding interleukin (IL)-11 receptor for development of agonists, antagonists, therapeutic and diagnostic reagents; antiproliferative/inflammatory agents
08/07/2003US20030149235 Peptide complex comprising expression vector for transfer of heterologous polynucleotides to endothelial cells; gene therapy; drug delivery
08/07/2003US20030148986 For therapy of atherosclerosis and other vascular diseases such as thrombosis, restenosis after angioplasty and/or stenting, and vein-graft disease after bypass surgery
08/07/2003US20030148978 Oligonucleotides antisense to mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
08/07/2003US20030148977 Delivering to mammalian cell that overexpresses pituitary tumor transforming gene carboxy-terminal (PTTG-C) formulation comprising polynucleotide to allow the polynucleotide to enter the cell, whereby expression of PTTG protein is prevented
08/07/2003US20030148973 For insertion and expression of foreign genes encoding tumor antigens for use in immunotherapy of cancer
08/07/2003US20030148972 Hereditary hemochromatosis gene
08/07/2003US20030148959 Anti-aging and wound healing compounds
08/07/2003US20030148958 For therapy and prophylaxis of muscular dystrophy
1 ... 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 ... 2916